Medizone Home
×

Meet Us At Our Booth At ARAB HEALTH 2019 – 28 to 31 January

We are looking forward to welcoming you at our booth at ARAB HEALTH - Stand No. (Za’abeel Hall 3)  Z3 / E.40. 28th to 31st January 2019. For more information visit ARAB HEALTH exhibitor ...

Meet us at Expopharm 2018 – Munich 10th to 13th October

We will have a booth again this year at expopharm Munich and hope that we can welcome you again in Hall B6 / Booth D17       For more information visit expopharm exhibitor ...

CHMP approves pegfilgrastim biosimilar, Pelgraz from Accord/Intas

Pelgraz – a pegylated G-CSF biosimilar, is latest addition to Accord Healthcare’s established portfolio of over 30 oncology treatments across Europe. Following marketing authorisation Accord Healthcare ...

FDA approves Mylan and Biocon’s Fulphila, the first biosimilar to Neulasta

Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim), co-developed with ...
Pages:«1234»